Therapeutic ranges of serum digoxin concentrations in patients with heart failure

American Journal of Cardiology

Volumn 109, Issue 12, 2012, Pages 1818-1821

  Goldberger, Zachary D ^a   Goldberger, Ary L ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIGOXIN;

CARDIOVASCULAR MORTALITY; CLINICAL PRACTICE; DIGITALIS INTOXICATION; DIGOXIN BLOOD LEVEL; EDITORIAL; EXERCISE TOLERANCE; HEART FAILURE; HOSPITALIZATION; HUMAN; KIDNEY CLEARANCE; MORBIDITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; RADIOIMMUNOASSAY; RANDOMIZED CONTROLLED TRIAL (TOPIC);

CARDIOTONIC AGENTS; DIGOXIN; HEART FAILURE; HUMANS; PRACTICE GUIDELINES AS TOPIC; REFERENCE VALUES;

EID: 84861619043     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2012.02.028     Document Type: Editorial

References (40)

1. W. Withering An Account of the Foxglove and Some of Its Medicinal Uses: With Practical Remarks on Dropsy, and Other Diseases 1785 M. Swinney Birmingham, England
2. Captopril-Digoxin Multicenter Research Group Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failure JAMA 259 1988 539 544
3. R. DiBianco, R. Shabetai, W. Kostuk, J. Moran, R.C. Schlant, R. Wright A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure N Engl J Med 320 1989 677 683
4. G.H. Guyatt, M.J. Sullivan, E.L. Fallen, H. Tihal, E. Rideout, S. Halcrow, S. Nogradi, M. Townsend, D.W. Taylor A controlled trial of digoxin in congestive heart failure Am J Cardiol 61 1988 371 375
5. V.C. Lee, D.C. Rhew, M. Dylan, E. Badamgarav, G.D. Braunstein, S.R. Weingarten Meta-analysis: angiotensin-receptor blockers in chronic heart failure and high-risk acute myocardial infarction Ann Intern Med 141 2004 693 704
6. M. Packer, M. Gheorghiade, J.B. Young, P.J. Costantini, K.F. Adams, R.J. Cody, L.K. Smith, L. Van Voorhees, L.A. Gourley, M.K. Jolly Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors RADIANCE study N Engl J Med 329 1993 1 7
7. B.F. Uretsky, J.B. Young, F.E. Shahidi, L.G. Yellen, M.C. Harrison, M.K. Jolly Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial PROVED investigative group J Am Coll Cardiol 22 1993 955 962
8. M. Packer End of the oldest controversy in medicine Are we ready to conclude the debate on digitalis? N Engl J Med 336 1997 575 576
9. Digitalis Investigation Group The effect of digoxin on mortality and morbidity in patients with heart failure N Engl J Med 336 1997 525 533
10. M. Jessup, W.T. Abraham, D.E. Casey, A.M. Feldman, G.S. Francis, T.G. Ganiats, M.A. Konstam, D.M. Mancini, P.S. Rahko, M.A. Silver, L.W. Stevenson, C.W. Yancy 2009 Focused update: ACCF/AHA guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation Circulation 119 2009 1977 2016
11. K. Dickstein, A. Cohen-Solal, G. Filippatos, J.J. McMurray, P. Ponikowski, P.A. Poole-Wilson, A. Strömberg, D.J. van Veldhuisen, D. Atar, A.W. Hoes, A. Keren, A. Mebazaa, M. Nieminen, S.G. Priori, K. Swedberg ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) Eur Heart J 29 2008 2388 2442
12. K. Haynes, D. Heitjan, P. Kanetsky, S. Hennessy Declining public health burden of digoxin toxicity from 1991 to 2004 Clin Pharmacol Ther 84 2008 90 94
13. Z. Hussain, J. Swindle, P.J. Hauptman Digoxin use and digoxin toxicity in the post-DIG trial era J Card Fail 12 2006 343 346
14. M.D. Flather, S. Yusuf, L. Kober, M. Pfeffer, A. Hall, G. Murray, C. Torp-Pedersen, S. Ball, J. Pogue, L. Moyé, E. Braunwald Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: A systematic overview of data from individual patients ACE-inhibitor Myocardial Infarction Collaborative Group Lancet 355 2000 1575 1581
15. R. Garg, S. Yusuf Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure Collaborative group on ACE inhibitor trials JAMA 273 1995 1450 1456
16. J.M. Brophy, L. Joseph, J.L. Rouleau Beta-blockers in congestive heart failure A Bayesian meta-analysis Ann Intern Med 134 2001 550 560
17. F.A. McAlister, N. Wiebe, J.A. Ezekowitz, A.A. Leung, P.W. Armstrong Meta-analysis: Beta-blocker dose, heart rate reduction, and death in patients with heart failure Ann Intern Med 150 2009 784 794
18. D.S. Budnitz, M.C. Lovegrove, N. Shehab, C.L. Richards Emergency hospitalizations for adverse drug events in older Americans N Engl J Med 365 2011 2002 2012
19. A.J. Gandhi, P.H. Vlasses, D.J. Morton, J.L. Bauman Economic impact of digoxin toxicity Pharmacoeconomics 12 1997 175 181
20. T.W. Smith, V.P. Butler Jr, E. Haber Determination of therapeutic and toxic serum digoxin concentrations by radioimmunoassay N Engl J Med 281 1969 1212 1216
21. S.J. Eisendrath, M.A. Sweeney Toxic neuropsychiatric effects of digoxin at therapeutic serum concentrations Am J Psychiatry 144 1987 506 507
22. D. Freitag, R. Bebee, B. Sunderland Digoxin-quinidine and digoxin-amiodarone interactions: frequency of occurrence and monitoring in Australian repatriation hospitals J Clin Pharm Ther 20 1995 179 183
23. N. Penugonda, A. Mohmand-Borkowski, J.F. Burke Dronedarone for atrial fibrillation: how does it compare with amiodarone? Cleve Clin J Med 78 2011 179 185
24. L.A. Siddoway Amiodarone: guidelines for use and monitoring Am Fam Physician 68 2003 2189 2196
25. W. Yamreudeewong, M. DeBisschop, L.G. Martin, D.L. Lower Potentially significant drug interactions of class III antiarrhythmic drugs Drug Saf 26 2003 421 438
26. K.E. Chan, J.M. Lazarus, R.M. Hakim Digoxin associates with mortality in ESRD J Am Soc Nephrol 21 2010 1550 1559
27. A. Ahmed, G. Gambassi, M.T. Weaver, J.B. Young, W.H. Wehrmacher, M.W. Rich Effects of discontinuation of digoxin versus continuation at low serum digoxin concentrations in chronic heart failure Am J Cardiol 100 2007 280 284
28. K.F. Adams Jr., J.H. Patterson, W.A. Gattis, C.M. O'Connor, C.R. Lee, T.A. Schwartz, M. Gheorghiade Relationship of serum digoxin concentration to mortality and morbidity in women in the DIG trial: A retrospective analysis J Am Coll Cardiol 46 2005 497 504
29. S.S. Rathore, J.P. Curtis, Y. Wang, M.R. Bristow, H.M. Krumholz Association of serum digoxin concentration and outcomes in patients with heart failure JAMA 289 2003 871 878
30. J. Lindenfeld, N.M. Albert, J.P. Boehmer, S.P. Collins, J.A. Ezekowitz, M.M. Givertz, S.D. Katz, M. Klapholz, D.K. Moser, J.G. Rogers, R.C. Starling, W.G. Stevenson, W.H. Tang, J.R. Teerlink, M.N. Walsh HFSA 2010 comprehensive heart failure practice guideline J Card Fail 16 suppl 2010 e1 e194
31. Heart Failure Society of America HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction - pharmacological approaches Pharmacotherapy 20 2000 495 522
32. M.D. Cabana, C.S. Rand, N.R. Powe, A.W. Wu, M.H. Wilson, P.A. Abboud, H.R. Rubin Why don't physicians follow clinical practice guidelines? A framework for improvement JAMA 282 1999 1458 1465
33. J. Lomas, G.M. Anderson, K. Domnick-Pierre, E. Vayda, M.W. Enkin, W.J. Hannah Do practice guidelines guide practice? The effect of a consensus statement on the practice of physicians N Engl J Med 321 1989 1306 1311
34. L.S. Phillips, W.T. Branch, C.B. Cook, J.P. Doyle, I.M. El-Kebbi, D.L. Gallina, C.D. Miller, D.C. Ziemer, C.S. Barnes Clinical inertia Ann Intern Med 135 2001 825 834
35. J.M. Grimshaw, I.T. Russell Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations Lancet 342 1993 1317 1322
36. R.M. Sameri, J.E. Soberman, C.K. Finch, T.H. Self Lower serum digoxin concentrations in heart failure and reassessment of laboratory report forms Am J Med Sci 324 2002 10 13
37. S.G. Terra, J.B. Washam, G.D. Dunham, W.A. Gattis Therapeutic range of digoxin's efficacy in heart failure: what is the evidence? Pharmacotherapy 19 1999 1123 1126
38. M. Gheorghiade, B. Pitt Digitalis Investigation Group (DIG) trial: a stimulus for further research Am Heart J 134 1997 3 12
39. S. Yusuf, J. Wittes, K. Bailey, C. Furberg Digitalis - a new controversy regarding an old drug The pitfalls of inappropriate methods Circulation 73 1986 14 18
40. S.S. Rathore, Y. Wang, H.M. Krumholz Sex-based differences in the effect of digoxin for the treatment of heart failure N Engl J Med 347 2002 1403 1411